Ok Biotech Valuation
| 4155 Stock | 22.10 0.05 0.23% |
At this time, the company appears to be fairly valued. Ok Biotech owns a latest Real Value of USD22.85 per share. The recent price of the company is USD22.1. Our model determines the value of Ok Biotech from analyzing the company fundamentals such as price to book of 1.49 X, and Return On Asset of 0.0155 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Ok Biotech's price fluctuation is very steady at this time. Calculation of the real value of Ok Biotech is based on 3 months time horizon. Increasing Ok Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the 4155 stock is determined by what a typical buyer is willing to pay for full or partial control of Ok Biotech Co. Since Ok Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 4155 Stock. However, Ok Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 22.1 | Real 22.85 | Hype 22.1 | Naive 22.62 |
The intrinsic value of Ok Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ok Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ok Biotech Co helps investors to forecast how 4155 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ok Biotech more accurately as focusing exclusively on Ok Biotech's fundamentals will not take into account other important factors: Ok Biotech Total Value Analysis
Ok Biotech Co is presently anticipated to have takeover price of 3.01 B with market capitalization of 3.21 B, debt of 401.76 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ok Biotech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.01 B | 3.21 B | 401.76 M |
Ok Biotech Investor Information
About 24.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.49. In the past many companies with similar price-to-book ratios have beat the market. Ok Biotech last dividend was issued on the 6th of July 2022. The entity had 1000:1102 split on the 5th of September 2023. Ok Biotech Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Ok Biotech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ok Biotech has an asset utilization ratio of 44.92 percent. This indicates that the Company is making USD0.45 for each dollar of assets. An increasing asset utilization means that Ok Biotech Co is more efficient with each dollar of assets it utilizes for everyday operations.Ok Biotech Ownership Allocation
Ok Biotech secures a total of 95.67 Million outstanding shares. Ok Biotech shows substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.Ok Biotech Profitability Analysis
The company reported the revenue of 1.26 B. Net Income was 43.46 M with profit before overhead, payroll, taxes, and interest of 186.83 M.About Ok Biotech Valuation
Our relative valuation model uses a comparative analysis of Ok Biotech. We calculate exposure to Ok Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ok Biotech's related companies.8 Steps to conduct Ok Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ok Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ok Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ok Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ok Biotech's revenue streams: Identify Ok Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ok Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ok Biotech's growth potential: Evaluate Ok Biotech's management, business model, and growth potential.
- Determine Ok Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ok Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for 4155 Stock Analysis
When running Ok Biotech's price analysis, check to measure Ok Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ok Biotech is operating at the current time. Most of Ok Biotech's value examination focuses on studying past and present price action to predict the probability of Ok Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ok Biotech's price. Additionally, you may evaluate how the addition of Ok Biotech to your portfolios can decrease your overall portfolio volatility.